MPI Research names ex-Cetero boss as head of lab science
This article was originally published in Scrip
MPI Research, the largest single-site preclinical CRO worldwide, has appointed Dr Roger Hayes vice-president and general manager of laboratory sciences. For nearly two decades, Dr Haynes has led strategic and research initiatives for large pharmaceutical companies, including Merck Research Laboratories and Parke-Davis Pharmaceuticals, which included both GLP and non-GLP preclinical studies as well as clinical trials. Most recently, he served as president of bioanalytical operations at Cetero Research where he focused on establishing overall corporate direction for bioanalytical and analytical services.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"